An Australian-first study demonstrating the effectiveness of a new immunization against respiratory syncytial virus (RSV) for ...

Fresno County health officials have confirmed the first pediatric deaths linked to flu and RSV this season, urging ...

A new study published in the Journal of American Medical Association showed that nirsevimab offers protection against a ...

Nirsevimab-resistant respiratory syncytial virus variants remain rare, but continued molecular surveillance is crucial. Read now.

Add articles to your saved list and come back to them any time. A Sydney GP administered an adult vaccine to a newborn baby months after health authorities discovered her medical centre had been ...

RSV leads to approximately 1.4 million hospitalizations and over 13,000 in-hospital deaths worldwide among infants under six months old. Beyfortus (nirservimab) offered strong protection against ...

Immunisation with nirsevimab reduced bronchiolitis-related hospitalisations among infants younger than 3 months who visited the emergency department (ED), according to a new study. Nirsevimab also ...

From next Monday, 17 March, free immunisation from respiratory syncytial virus (RSV) will be available to all newborn babies. It will mean all newborn babies in NSW can be protected against serious ...

A pooled analysis of data for AstraZeneca and Sanofi's respiratory syncytial virus (RSV) antibody nirsevimab has concluded that the drug is almost 80% effective at preventing lower respiratory ...

March 6, 2025 — Carolyn Figurelle was in Las Vegas getting ready for her sister-in-law’s wedding when her 6-month-old son’s breathing became shallow. Carolyn, in the emergency room in ...